FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

Journal: Journal of Clinical Investigation

Published: 2020-09-01

DOI: 10.1172/jci130323

Affiliations: 20

Authors: 25

Go to article
Institutions Share
The University of North Carolina at Chapel Hill (UNC), United States of America (USA) 0.31
UNC Lineberger Comprehensive Cancer Center, United States of America (USA) 0.29
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain 0.07
Hospital Clinic of Barcelona, Spain 0.07
Spanish Research Group on Breast Cancer (GEICAM), Spain 0.06
Biomedical Research Networking Centers (CIBER), Spain 0.04
Baylor College of Medicine (BCM), United States of America (USA) 0.04
Hospital Clínico Universitario de Valencia, Spain 0.03
Hospital Universitario Fundación Jiménez Díaz (FJD), UAM, Spain 0.01
Provincial Hospital of Castellón, Spain 0.01
SOLTI Breast Cancer Research Group, Spain 0.01
Biomedical Research Institute (INCLIVA), Spain 0.01
Hospital del Mar Medical Research Institute (IMIM), Spain 0.01
Hospital del Mar, Spain 0.01
Pompeu Fabra University (UPF), Spain 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER